Exploration of the ASCO and ESMO value frameworks for cancer drugs.

6512Background: In 2015 both ASCO and ESMO proposed frameworks to quantify the value of cancer drugs. We sought to examine these frameworks for drugs approved by the U.S. Food and Drug Administrati...